FI820983L - Acyl-kinolinonderivat, foerfarande foer deras framstaellning, dessa innehaollande farmaceutiska preparat samt deras anvaendning - Google Patents

Acyl-kinolinonderivat, foerfarande foer deras framstaellning, dessa innehaollande farmaceutiska preparat samt deras anvaendning

Info

Publication number
FI820983L
FI820983L FI820983A FI820983A FI820983L FI 820983 L FI820983 L FI 820983L FI 820983 A FI820983 A FI 820983A FI 820983 A FI820983 A FI 820983A FI 820983 L FI820983 L FI 820983L
Authority
FI
Finland
Prior art keywords
deras
kinolinonderivat
acyl
pharmaceutical preparation
samt
Prior art date
Application number
FI820983A
Other languages
English (en)
Other versions
FI77853B (fi
FI77853C (fi
Inventor
Richard Goeschke
Pier Giorgio Ferrini
Alfred Sallmann
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI820983L publication Critical patent/FI820983L/fi
Publication of FI77853B publication Critical patent/FI77853B/fi
Application granted granted Critical
Publication of FI77853C publication Critical patent/FI77853C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/241,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • C07D265/26Two oxygen atoms, e.g. isatoic anhydride
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/38Oxygen atoms in positions 2 and 3, e.g. isatin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI820983A 1981-03-24 1982-03-22 Foerfarande foer framstaellning av tautomera, antiallergiskt verksamma kinolinonderivat och deras salter. FI77853C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH198681 1981-03-24
CH198681 1981-03-24

Publications (3)

Publication Number Publication Date
FI820983L true FI820983L (fi) 1982-09-25
FI77853B FI77853B (fi) 1989-01-31
FI77853C FI77853C (fi) 1989-05-10

Family

ID=4223231

Family Applications (1)

Application Number Title Priority Date Filing Date
FI820983A FI77853C (fi) 1981-03-24 1982-03-22 Foerfarande foer framstaellning av tautomera, antiallergiskt verksamma kinolinonderivat och deras salter.

Country Status (22)

Country Link
US (1) US4476132A (fi)
EP (1) EP0062001B1 (fi)
JP (1) JPH066576B2 (fi)
AR (4) AR242189A1 (fi)
AT (1) ATE27451T1 (fi)
AU (1) AU560003B2 (fi)
CY (1) CY1412A (fi)
DE (1) DE3276432D1 (fi)
DK (1) DK159427C (fi)
ES (7) ES8400092A1 (fi)
FI (1) FI77853C (fi)
GB (1) GB2095668B (fi)
GR (1) GR78345B (fi)
HK (1) HK3988A (fi)
HU (1) HU192103B (fi)
IE (1) IE53158B1 (fi)
IL (1) IL65327A0 (fi)
MY (1) MY8700806A (fi)
NO (1) NO160074C (fi)
NZ (1) NZ200106A (fi)
PT (1) PT74634B (fi)
ZA (1) ZA821957B (fi)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58219166A (ja) * 1982-06-14 1983-12-20 Nippon Shinyaku Co Ltd 4−キノロン誘導体
JPS58225065A (ja) * 1982-06-21 1983-12-27 Nippon Shinyaku Co Ltd 2−キノロン誘導体
US4675432A (en) * 1986-08-29 1987-06-23 American Cyanamid Company Method for the preparation of anilinofumarate
US6034100A (en) * 1993-03-10 2000-03-07 Otsuka Pharmaceutical Co., Ltd. Method for inhibiting cytokine secretion
MXPA03002907A (es) * 2000-10-02 2003-06-24 Janssen Pharmaceutica Nv Antagonistas receptores metabotropicos de glutamato.
PL218788B1 (pl) * 2002-03-29 2015-01-30 Janssen Pharmaceutica Nv Znakowane radioaktywnie pochodne chinoliny i jej zastosowanie
CN105073729A (zh) 2012-10-16 2015-11-18 詹森药业有限公司 RORγt的苯基连接的喹啉基调节剂
EP2909189B8 (en) 2012-10-16 2017-04-19 Janssen Pharmaceutica NV Heteroaryl linked quinolinyl modulators of ror-gamma-t
WO2014062658A1 (en) 2012-10-16 2014-04-24 Janssen Pharmaceutica Nv Methylene linked quinolinyl modulators of ror-gamma-t
US9328095B2 (en) 2013-10-15 2016-05-03 Janssen Pharmaceutica Nv Heteroaryl linked quinolinyl modulators of RORgammat
US9403816B2 (en) 2013-10-15 2016-08-02 Janssen Pharmaceutica Nv Phenyl linked quinolinyl modulators of RORγt
US9221804B2 (en) 2013-10-15 2015-12-29 Janssen Pharmaceutica Nv Secondary alcohol quinolinyl modulators of RORγt
US9284308B2 (en) 2013-10-15 2016-03-15 Janssen Pharmaceutica Nv Methylene linked quinolinyl modulators of RORγt
US10555941B2 (en) 2013-10-15 2020-02-11 Janssen Pharmaceutica Nv Alkyl linked quinolinyl modulators of RORγt
US9346782B2 (en) 2013-10-15 2016-05-24 Janssen Pharmaceutica Nv Alkyl linked quinolinyl modulators of RORγt
WO2015057626A1 (en) 2013-10-15 2015-04-23 Janssen Pharmaceutica Nv QUINOLINYL MODULATORS OF RORyT

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB830832A (en) * 1957-02-15 1960-03-23 Ici Ltd New quinolones and therapeutic compositions containing them
GB1013224A (en) * 1962-06-21 1965-12-15 Ici Ltd Heterocyclic aminoethanols
CH529136A (de) * 1966-09-29 1972-10-15 Ciba Geigy Ag Verfahren zur Herstellung von heterocyclischen Carbonsäuren
US3496184A (en) * 1969-03-18 1970-02-17 Ciba Geigy Corp Cyclopropylmethoxy-3-quinoline carboxylic acids and esters
DE2103805C3 (de) * 1970-01-28 1980-03-20 Sumitomo Chemical Co., Ltd., Osaka (Japan) Verfahren zur Herstellung von N-substituierten 6,7-Methylendioxy-4chinolonen
GB1334705A (en) * 1970-06-19 1973-10-24 Ici Ltd Pharmaceutical compositions containing kynurenic acid derivatives
CA942748A (en) * 1970-09-18 1974-02-26 Venkatachala L. Narayanan 1-aziridinylcarbonyl substituted-3-quinolinecarboxylic acid compounds
US4190659A (en) * 1973-08-27 1980-02-26 Sandoz, Inc. Pharmaceutical preparation and use of 4-hydroxy-2-quinolinone-3-carboxylic acid esters
US4086349A (en) * 1975-07-30 1978-04-25 Mitsubishi Yuka Pharmaceutical Co., Ltd. Quinolopyran-4-one-2-carboxylic acid derivatives and salts thereof as novel compounds and as medicines for treatment of allergic asthma
JPS609511B2 (ja) * 1976-07-16 1985-03-11 大塚製薬株式会社 5−カルボスチリルメタノ−ル誘導体
JPS609713B2 (ja) * 1976-10-08 1985-03-12 大塚製薬株式会社 カルボスチリル誘導体
US4186201A (en) * 1977-02-07 1980-01-29 Riker Laboratories, Inc. Methods of using 8(tetrazol-5-ylcarbamoyl)isoquinoline compounds
US4187309A (en) * 1977-06-20 1980-02-05 Sandoz, Inc. 4-Hydroxy-2-quinolinone-3-carboxylic acids and salts thereof
US4119720A (en) * 1977-07-06 1978-10-10 Sandoz, Inc. Unsaturated esters of 4-hydroxy-2-quinolinone-3-carboxylic acids and salts thereof
DE2806879A1 (de) * 1978-02-17 1979-08-23 Sandoz Ag 4-hydroxy-2-chinolinon-3-carbonsaeure- esterderivate

Also Published As

Publication number Publication date
AR240044A1 (es) 1990-01-31
DK159427B (da) 1990-10-15
IL65327A0 (en) 1982-05-31
HU192103B (en) 1987-05-28
NO160074B (no) 1988-11-28
DE3276432D1 (en) 1987-07-02
ES510685A0 (es) 1983-10-16
ATE27451T1 (de) 1987-06-15
GB2095668A (en) 1982-10-06
JPH066576B2 (ja) 1994-01-26
FI77853B (fi) 1989-01-31
PT74634A (de) 1982-04-01
IE53158B1 (en) 1988-08-03
EP0062001A3 (en) 1983-01-26
ES8503665A1 (es) 1985-03-01
ES8503661A1 (es) 1985-03-01
GB2095668B (en) 1985-04-11
MY8700806A (en) 1987-12-31
HK3988A (en) 1988-01-22
GR78345B (fi) 1984-09-26
AR242189A1 (es) 1993-03-31
IE820670L (en) 1982-09-24
ES523338A0 (es) 1985-03-01
ES8503334A1 (es) 1985-02-16
AU560003B2 (en) 1987-03-26
ES523341A0 (es) 1985-02-16
ES8400092A1 (es) 1983-10-16
AU8181982A (en) 1982-09-30
NZ200106A (en) 1985-07-31
ES8503664A1 (es) 1985-03-01
ES523340A0 (es) 1985-03-01
ES523337A0 (es) 1985-03-01
EP0062001A2 (de) 1982-10-06
CY1412A (en) 1988-04-22
ES8503663A1 (es) 1985-03-01
NO820959L (no) 1982-09-27
ZA821957B (en) 1983-02-23
EP0062001B1 (de) 1987-05-27
JPS57192366A (en) 1982-11-26
FI77853C (fi) 1989-05-10
AR242376A1 (es) 1993-03-31
AR240739A1 (es) 1990-10-31
ES8503662A1 (es) 1985-03-01
NO160074C (no) 1989-03-08
PT74634B (de) 1984-11-26
DK159427C (da) 1991-03-18
ES523342A0 (es) 1985-03-01
DK130382A (da) 1982-09-25
ES523339A0 (es) 1985-03-01
US4476132A (en) 1984-10-09

Similar Documents

Publication Publication Date Title
FI822770A0 (fi) Bensazepin-2-oner, foerfarande foer deras framstaellning, farmaceutiska preparat innehaollande dessa foereningar samt deras terapeutiska anvaendning
FI823013L (fi) Ny lipidfraktion, dess framstaellning samt densamma innehaollande farmaceutiska blandningar
ATE34076T1 (de) Shampoo.
NO861469L (no) Preparat for motvirkning av daarlig aande.
NL189071C (nl) Cosmetisch preparaat.
FI820983L (fi) Acyl-kinolinonderivat, foerfarande foer deras framstaellning, dessa innehaollande farmaceutiska preparat samt deras anvaendning
FI890488A0 (fi) Vaextextrakt innehaollande farmaceutiska preparat samt foerfarande foer framstaellning daerav.
FI822187L (fi) Farmaceutiska preparat
DE3280040D1 (de) Winkelgeschwindigkeitsmesser.
FI823938L (fi) N-substituerade 2-pyridylindoler, foerfarande foer deras framstaellning, dessa foereningar innehaolfarmaceutiska preparat, samt deras anvaendning
FI874382A0 (fi) Farmaceutiska preparat.
FI833489A0 (fi) N-substituerade-2-(1-imidazolyl)-indoler, foerfarande foer deras framstaellning, dessa foereningar innehaollande farmaceutiska preparat samt deras anvaendning
FI834138A0 (fi) Heterocyklylfoereningar, dessa foereningar innehaollande farmaceutiska preparat samt deras anvaendning
FI823304A0 (fi) Amino-oxazolylfoereningar, foerfarande foer deras framstaellning, dessa foereningar innehaollande farmaceutiska preparat samt anvaendning av de sistnaemnda
FI841740A (fi) Aminolaogalkyl-penem-foereningar, foerfarande foer deras framstaellning, dessa foereningar innehaollande farmaceutiska preparat och anvaendning av de sistnaemnda.
FI853123A0 (fi) Metallkomplexer av bis-indolfoereningar samt vattenhaltiga farmaceutiska blandningar innehaollande desamma.
FI810874L (fi) Farmaceutiska preparat
FI812536L (fi) Nya diaryl-imidazol-foereningar foerfaranden foer deras framstaellning dessa foereningar innehaollande farmaceutiska preparat samt deras anvaendning
FI883747A0 (fi) Topiskt anvaendbara farmaceutiska preparat.
NO852623L (no) Preparat inneholdende te-ekstrakt.
FI823690A0 (fi) Aminocyklopentanestrar och deras framstaellning och farmaceutiska preparat
FI834140A0 (fi) Heterocyklyltiofoereningar, dessa foereningar innehaollande farmaceutiska preparat samt deras anvaendning
FI822033L (fi) Imidatsolylpropionitriler, foerfarande foer framstaellning av dessa foerenigar samt biocider innehaollande dessa foereningar
NL193821B (nl) Farmaceutisch preparaat.
FI824170A0 (fi) Imidazobensodiazepiner, foerfarande foer deras framstaellning, dessa foereningar innehaollande farmaceutiska preparat och deras anvaendning

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: CIBA-GEIGY AG